COCCO, CRISTINA
 Distribuzione geografica
Continente #
EU - Europa 170.753
NA - Nord America 6.260
AS - Asia 3.257
SA - Sud America 494
Continente sconosciuto - Info sul continente non disponibili 269
AF - Africa 71
OC - Oceania 23
Totale 181.127
Nazione #
IT - Italia 166.988
US - Stati Uniti d'America 6.137
NL - Olanda 1.900
SG - Singapore 1.240
CN - Cina 1.170
SE - Svezia 511
BR - Brasile 387
UA - Ucraina 375
DE - Germania 303
VN - Vietnam 285
FI - Finlandia 207
FR - Francia 162
HK - Hong Kong 139
GB - Regno Unito 135
CA - Canada 70
IN - India 66
BD - Bangladesh 62
KR - Corea 61
JP - Giappone 44
AR - Argentina 34
RU - Federazione Russa 32
ES - Italia 29
PL - Polonia 27
MX - Messico 26
ZA - Sudafrica 26
IQ - Iraq 25
PK - Pakistan 25
TR - Turchia 23
AU - Australia 21
EC - Ecuador 18
UZ - Uzbekistan 15
ID - Indonesia 14
CZ - Repubblica Ceca 13
MA - Marocco 13
VE - Venezuela 13
CL - Cile 12
BE - Belgio 11
CH - Svizzera 11
IR - Iran 10
AT - Austria 9
CO - Colombia 9
IE - Irlanda 9
JM - Giamaica 9
AE - Emirati Arabi Uniti 8
EU - Europa 8
MY - Malesia 8
SA - Arabia Saudita 8
TN - Tunisia 8
JO - Giordania 7
UY - Uruguay 7
PY - Paraguay 6
TH - Thailandia 6
EG - Egitto 5
KE - Kenya 5
OM - Oman 5
PH - Filippine 5
AL - Albania 4
AZ - Azerbaigian 4
BH - Bahrain 4
CR - Costa Rica 4
PE - Perù 4
PS - Palestinian Territory 4
RO - Romania 4
GY - Guiana 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LT - Lituania 3
PT - Portogallo 3
TT - Trinidad e Tobago 3
BS - Bahamas 2
DK - Danimarca 2
DZ - Algeria 2
ET - Etiopia 2
GE - Georgia 2
GT - Guatemala 2
LK - Sri Lanka 2
NG - Nigeria 2
NO - Norvegia 2
RS - Serbia 2
SY - Repubblica araba siriana 2
BB - Barbados 1
BG - Bulgaria 1
BO - Bolivia 1
BW - Botswana 1
CG - Congo 1
CI - Costa d'Avorio 1
DM - Dominica 1
EE - Estonia 1
GA - Gabon 1
GH - Ghana 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
IS - Islanda 1
KH - Cambogia 1
KI - Kiribati 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
Totale 180.850
Città #
Cagliari 163.348
Uta 2.989
Amsterdam 1.886
Singapore 685
Ashburn 517
San Jose 446
Fairfield 441
Chandler 412
Nyköping 295
Woodbridge 293
Dallas 270
Ann Arbor 241
Boardman 236
Wilmington 233
Beijing 222
Houston 198
Jacksonville 192
Seattle 183
Los Angeles 165
Cambridge 163
Shanghai 136
Dearborn 135
Helsinki 126
Hong Kong 124
Santa Clara 123
New York 113
Council Bluffs 109
Ho Chi Minh City 81
Lauterbourg 80
The Dalles 74
Nanjing 70
Hefei 65
Hanoi 59
Seoul 59
Boston 58
Munich 57
Rome 51
Dong Ket 50
São Paulo 47
Buffalo 43
Guangzhou 40
Tokyo 38
Phoenix 36
Milan 35
Chicago 31
Orem 31
Redwood City 29
San Diego 29
Columbus 28
Tianjin 26
Changsha 24
Toronto 23
Nanchang 22
Shenyang 22
Brooklyn 21
Verona 21
Sydney 20
Warsaw 20
Denver 19
Frankfurt am Main 19
San Mateo 19
Atlanta 18
Chennai 18
Jiaxing 18
Johannesburg 18
Montreal 18
Lappeenranta 17
London 17
Redondo Beach 17
Hebei 16
Paris 15
Rio de Janeiro 15
Belo Horizonte 14
Jinan 14
Nuremberg 14
San Francisco 14
Da Nang 13
Falls Church 13
Auburn Hills 12
Düsseldorf 12
Orange 12
Stockholm 12
Baghdad 11
Brussels 11
Tashkent 11
Turku 11
Hangzhou 10
Kunming 10
Mexico City 10
Mumbai 10
Norwalk 10
Pisa 10
Renton 10
Brno 9
Mountain View 9
Poplar 9
Can Tho 8
Dublin 8
Haiphong 8
Jinhua 8
Totale 176.118
Nome #
VGF peptide profiles in Type 2 diabetic patients' plasma and in obese mice 4.799
VGF protein and its C-terminal derived peptides in amyotrophic lateral sclerosis: Human and animal model studies 4.792
Photoperiod Regulates vgf-Derived Peptide Processing in Siberian Hamsters 4.373
Involvement of nigral oxytocin in locomotor activity: a behavioral, immunohistochemical and lesion study in male rats 4.099
Profiles of VGF peptides in the rat brain and their modulations after Phencyclidine treatment 4.087
Targeting Substantia Nigra through Oxytocin Receptors. 3.883
VGF: an inducible gene product, precursor of a diverse array of neuro-endocrine peptides and tissue-specific disease biomarkers. 3.866
VGF and Type II Diabetes: Decrease of VGF fragment levels in adipose tissues of diet-induced obese mice 3.863
Selective expression of TLQP-21 and other VGF peptides in gastric neuroendocrine cells and modulation by feeding 3.863
Parkinson’s disease: changes in TLQP and related peptide/s in 6-OHDA treated rat and in human plasma 3.759
VGF-peptides in the Siberian hamster 3.694
Hypothalamic over-expression of VGF in the Siberian hamster increases energy expenditure and reduces body weight gain 3.662
VGF peptides: differential expression in motor neurons, and possible changes in Amyotrophic Lateral Sclerosis (ALS). 3.646
Distribution of VGF peptides in the human cortex and their selective changes in Parkinson's and Alzheimer's diseases 3.609
A multidisciplinary approach to mental illness: Do inflammation, telomere length and microbiota form a loop? A protocol for a cross-sectional study on the complex relationship between inflammation, telomere length, gut microbiota and psychiatric disorders 3.519
Selective expression of vgf-derived peptides in gastric endocrine cells: differential modulation of TLQP-peptides by feeding 3.438
VGF changes during the estrous cycle: a novel endocrine role for TLQP peptides? 3.367
Pituitary gonadotropins and autoimmunity 3.336
VGF peptides in hypothalamus-pituitary axis in the rat estrous cycle 3.213
Reduction of Total Brain and Cerebellum Volumes Associated With Neuronal Autoantibodies in Patients With APECED 3.205
Attività motoria e interazione tra ossitocina, dopamina ed acido glutammico nella Sostanza Nera del ratto maschio: uno studio comportamentale, immunoistochimico e di lesione 3.201
Differential distribution of VGF-derived peptides in the adrenal medulla and evidence for their selective modulation 3.161
Differences in telomere length between patients with bipolar disorder and controls are influenced by lithium treatment 3.159
Oxytocin induces penile erection when injected into the ventral subiculum: role of nitric oxide and glutamic acid 3.095
Median eminence dopaminergic terminals: a novel auto-immune target in neuro/endocrine disease 2.977
TLQP peptides in amyotrophic lateral sclerosis: possible blood biomarkers with a neuroprotective role 2.949
Novel neuronal and endocrine autoantibody targets in autoimmune polyendocrine syndrome type 1 2.903
Telomere attrition and inflammatory load in severe psychiatric disorders and in response to psychotropic medications 2.900
Oxytocin induces penile erection and yawning when injected into the bed nucleus of the stria terminalis: A microdialysis and immunohistochemical study 2.877
VGF peptides as novel biomarkers in Parkinson’s disease 2.831
Targeting Substantia Nigra through Oxytocin Receptors 2.769
Anterior pituitary autoantibodies in patients with type 1 diabetes mellitus: methodological problems and clinical correlations 2.717
null 2.647
Oxytocin injected into the ventral tegmental area induces penile erection and increases extracellular dopamine in the nucleus accumbens and paraventricular nucleus of the hypothalamus of male rats 2.646
Modulation of the VGF derived peptides NERP-1 and –2 upon salt loading and dehydration: novel actors in water homeostasis? 2.589
Oxytocin induces penile erection when injected into the ventral tegmental area of male rats: role of nitric oxide and cyclic GMP 2.478
VGF peptides and peripheral activation of energy expenditure 2.464
Multiple immunofluorescence technology 2.365
TLQP 21 and other Pro-VGF peptides: peripheral and central alternative peptide products from the neuro-endocrine vgf gene and evidence for their modulation. 2.357
VGF metabolic-related gene: distribution of its derived peptides in mammalian pancreatic islets 2.356
The hypothalamic-pituitary axis and autoantibody related disorders 2.324
Alzheimer’s disease related vgf-peptide/s in the mammalian nervous system 2.279
The pesticide fipronil injected into the substantia nigra of male rats decreases striatal dopamine content: a neurochemical, immunohistochemical and behavioral study 2.245
VGF Peptides in Cerebrospinal Fluid of Patients with Dementia with Lewy Bodies 2.240
Photoperiodic changes in adiposity increase sensitivity of female Siberian hamsters to systemic VGF derived peptide TLQP-21 2.198
Effect of TLQ-21 peripheral injection on food intake and reproduction mechanisms in female Siberian Hamsters 1.994
Selective VGF-peptide/s changes in human neurodegenerative diseases. 1.975
Novel VGF-derived peptides in homeostatic control: blood and tissue changes of the amidated NERP peptide/s upon salt loading and dehydration 1.954
Dynamic of TLQP-peptides upon fasting 1.855
Analysis of hypothalamic VGF-immunoreactivity in the Siberian Hamster. 1.806
HYPOTHALAMIC-Pituitary axis in aps i: novel autoantibody targets possibly related to endocrine disfunctions 1.752
Pro-VGF-derived peptides induce penile erection in male rats: possible involvement of oxytocin 1.716
Misurazione dei livelli dei peptidi C-terminali di VGF nel plasma di pazienti affetti dalla malattia di Parkinson per una diagnosi precoce 1.716
Le malattie autoimmuni dell'ipofisi e dell'Ipotalamo 1.495
Gastric immunolocalization and plasma profiles of acyl-ghrelin in fasted and fasted-refed prepuberal gilts 1.459
Tissue cryoarraies: a novel approach to autoantibodies detection 1.303
Tunable, colour coded simultaneus viewing in multiple fluorescence: a novel approach to gene-product espression dynamics. 1.262
Median eminence dopaminergic nerve terminals: a novel target in autoimmune polyendocrine syndrome? 1.237
Identification of novel cerebrospinal fluid biomarker candidates for dementia with Lewy bodies: a proteomic approach 1.209
The novel neuroendocrine peptides “nerp-1” and “nerp-2”: changes in altered water balance 1.179
Median eminence dopaminergic terminals: a novel autoimmune target 1.111
Brain-reactive autoantibodies in neuropsychiatric systemic lupus erythematosus 1.073
Embedding media for cryomicrotomy: an applicative reappraisal 1.034
Autoantibodies to anterior pituitary cells and hypothalamic neurons in a girl with type 1 autoimmune polyendocrinopathy (APECED), associated to growth and pubertal retardation 1.022
Autoimmune target within the hypothalamic median eminence in patients with a polyendocrine disease 1.015
Cellule biocitinate nel pancreas umano 1.008
TLQP-21 changes in response to a glucose load 924
Equipment testing and tuning: the cold-knife cryomicrotome microm HM-560 884
Autoantibodies targets in the hypothalamic-hypophyseal complex: possibile role in type 1 autoimmune polyendocrinopaty with growth arrest 855
VGF peptides upon osmotic stimuli: Changes in neuroendocrine regulatory peptides 1 and 2 in the hypothalamic-pituitary-axis and plasma 785
Oxytocin-conjugated saporin injected into the substantia nigra of male rats alters the activity of the nigrostriatal dopaminergic system: A behavioral and neurochemical study 761
Autoantibodies to anterior pituitary cells and hypothalamic neurons in a girl with type I autoimmune polyendocrinopathy (APECED), associated to growth and pubertal retardation. 704
Pathologically Decreased CSF Levels of Synaptic Marker NPTX2 in DLB Are Correlated with Levels of Alpha-Synuclein and VGF 666
Brain-Biomarker Changes in Body Fluids of Patients with Parkinson’s Disease 486
VGF modifications related to nigrostriatal dopaminergic neurodegeneration induced by the pesticide fipronil in adult male rats 457
A Pilot Interaction Analysis of Gut Microbiota and Peripheral Markers of Aging in Severe Psychiatric Disorders: A Role for Lachnoclostridium? 428
Lower Plasma Levels of Selective VGF (Non-Acronymic) Peptides in Bipolar Disorder: Comparative Analysis Reveals Distinct Patterns across Mood Disorders and Healthy Controls 251
The NR4A2/VGF pathway fuels inflammation-induced neurodegeneration via promoting neuronal glycolysis 195
A beginner’s guide to immunohistochemistry 166
Inhibition of α-Glucosidase Activity and Islet Amyloid PolyPeptide Fibril Formation by Rubus ulmifolius Fruit Extract: A Potential Therapeutic Approach for Type 2 Diabetes Mellitus 142
NERP-1 modifications in amyotrophic lateral sclerosis 138
VGF and Its Derived Peptides in Amyotrophic Lateral Sclerosis 102
Early Dopaminergic Dysfunction Induces PRO-VGF Changes in Blood and Brain of Rats with Alpha-Synuclein Overexpression 96
VGF AQEE- and GGEE-peptides differentiate between dementia types 67
VGF INVOLVEMENT ON PARKINSON’S DISEASE 26
Effect of α-Synuclein Overexpression on NAPP-129 and TLQP-62 in Rat Brain and Plasma 19
Totale 181.127
Categoria #
all - tutte 216.099
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 216.099


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20227.055 0 0 368 782 863 512 581 351 856 1.026 970 746
2022/202312.379 797 1.723 1.833 1.118 851 1.099 641 892 837 955 1.115 518
2023/202411.587 832 616 559 793 1.244 1.734 1.765 831 863 712 816 822
2024/202516.673 2.994 4.325 2.673 2.013 1.092 1.107 1.426 147 246 197 200 253
2025/20268.220 400 290 553 541 631 440 1.333 354 2.412 700 408 158
2026/2027825 383 240 202 0 0 0 0 0 0 0 0 0
Totale 181.127